Johnson & Johnson (NYSE:JNJ) ranks among the best set-it-and-forget-it stocks to buy. Asad Haider, a Goldman Sachs analyst, ...

Mental health has not always been talked about within communities of color, but that is starting to shift because of people ...

The latest update from the National Hurricane Center now shows a medium chance of development near Florida or along the ...

Verizon Communications Inc. stands out as the top Dow dividend pick with strong cash flow and value potential. Click for my ...

Atai Life Sciences is making incremental progress towards opening door for a first psychedelic treatment for depression. Read ...

Many of the traditions we know today began in postwar America — including the very color of many modern wedding dresses.

Sonya Johnson, 41, started taking drugs at age 11, when a man who was sexually abusing her gave them to her behind her ...

A federal court denied Johnson & Johnson's motion to implement a 340B drug rebate model, siding with HHS and hospitals who ...

Beckley Psytech’s psychedelic drug has successfully reduced the symptoms of depression in a phase 2 study, triggering the next stage of a planned merger with mental health-focused company Atai Life ...

A federal judge has rejected Johnson & Johnson’s challenge to block its proposed rebate model under the 340B Drug Pricing Program, Bloomberg Law reported June 27. Judge Rudolph Contreras of the U.S.